Table 2.
Results of 6- and 12-week baseline change in MCS.
| NIA (N = 18) | MAD (N = 20) | |
|---|---|---|
| MCS (HVLT + BVMT delayed): W6 | ||
| Mean (SD) | 2.9 (3.4) | 6.6 (7.4) |
| Range | [0, 11] | [0, 23] |
| Missing | 9 (50.0%) | 8 (40.0%) |
| MCS (HVLT + BVMT delayed): W12 | ||
| Mean (SD) | 2.4 (3.9) | 6.8 (7.6) |
| Range | [0, 12] | [0, 20] |
| Missing | 9 (50.0%) | 7 (35.0%) |
| MCS change (HVLT + BVMT delayed): W6 − BL | ||
| Mean (SD) | −0.3 (3.9) | 1.2 (2.4) |
| Range | [−10, 4] | [−2, 7] |
| Missing | 9 (50.0%) | 8 (40.0%) |
| MCS change (HVLT + BVMT delayed): W12 − BL | ||
| Mean (SD) | −0.8 (3.8) | 0.9 (2) |
| Range | [−10, 3] | [−2, 4] |
| Missing | 9 (50.0%) | 7 (35.0%) |
Nine data points are “missing” for the NIA group, given that only half of those enrolled/randomized (nine of 18) completed the study. Eight data points are “missing” for the MAD group given only 12/20 of those enrolled/randomized completed the study. One additional patient in the MAD group did not complete the HVLT and BVMT needed for MCS at week 6, resulting in an additional “missing” data point at week 6.